Publications Archive
This archive contains all documents published by cep over the last few years
- cepAdhoc: Incisive comment on current EU policy issues
- cepPolicyBrief: Concise reviews of EU proposals (Regulations, Directives, Green Papers, White Papers, Communications) – including an executive summary
- cepInput: Impulse to current challenges of EU policies
- cepStudy: Comprehensive examination of EU policy proposals affecting the economy
2019
cepPolicyBrief: Climate Protection Vision 2050 (Communication)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/1.png)
The EU Commission has summarised its long-term climate policy targets in a Communication. Under the heading “A Clean Planet for all” it presents its vision for a prosperous, modern, competitive and climate-neutral economy.
More2019
cepPolicyBrief: Credit servicers, credit purchasers and the recovery of collateral (Directive)
The EU Commission wants to achieve a reduction in the high stocks of non-performing loans. A Directive on credit servicers, credit purchasers and the recovery of collateral aims to prevent a future increase.
More2019
cepPolicyBrief: Reform Delivery Tool (Regulation)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/2.png)
As part of a Reform Support Programme, the Commission plans to make available around € 22 billion to EU Member States for structural reforms. For this purpose, the EU Commission has proposed a Regulation.
More2019
cepPolicyBrief: FinTech Action Plan (Communication)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/2.png)
The European Commission wants to create a more competitive and innovative European financial sector with initiatives on new financial technologies. Therefore it has submitted a FinTech action plan.
More2019
cepPolicyBrief: Protection for Whistleblowers (Directive)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/3.png)
Whistleblowers are to be given better protection in the EU which will improve the enforcement of EU law. For this purpose, the EU Commission wants a Directive to create mechanisms with minimum standards to protect whistleblowers against retaliation for reporting breaches of specific EU law.
More2018
cepPolicyBrief: Early Childhood Education and Care (Recommendation)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/3.png)
The provision of early childhood education and care (ECEC) in the EU is to be expanded and its quality improved. The corresponding proposal by the EU Commission for a Council Recommendation relates to children up to compulsory school age, their parents and the staff in ECEC facilities.
More2018
cepAdhoc: Reform of the European Stability Mechanism (ESM)
On 4 December 2018, the Eurogroup agreed on a reform of the European Stability Mechanism (ESM). In the run-up to forthcoming changes to the ESM Treaty, cep analyses the Eurogroup’s political agreements.
More2018
cepPolicyBrief: “New Deal” for Consumers – Part 2: EU Consumer Law (Directive)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/2.png)
In view of increasing EU-wide violations, the EU-Commission wants to strengthen the enforcement of, and thus improve compliance with, EU consumer protection law. In the context of its “New Deal for Consumers”, it has submitted a corresponding Directive.
More2018
cepAdhoc: Derivatives clearing after Brexit
Following Brexit on 29 March 2019, the United Kingdom will become a "third country". Financial and other companies domiciled in the EU will then no longer be able to easily fulfil their obligation to clear derivatives with "central counterparties" (CCPs) in London. In a cepAdhoc, short and medium-term EU priorities for derivatives clearing are analysed.
More2018
cepPolicyBrief: Exemption from SPC Protection for Medicines (Regulation)
![](/_assets/186a90b15ff3c8a6307eea08f44f39f4/Icons/Status/3.png)
By way of an exemption from protection certificates, the EU wants to permit the manufacture of generics and so-called biosimilars for export, even where the original medicine is still protected by a certificate in the EU. Using this exemption, it wants to remedy competitive disadvantages for EU manufacturers and strengthen its generics and biosimilars industry.
More